Anti-tumor protein isolated from ink of a sea slug destroys various kinds of cancers
11-Jul-2007
In vitro and in vivo experiments show that APIT efficiently destroys various kinds of cancers and could potentially also be used for the treatment of cancer becoming resistant to chemotherapy. This agreement grants Celonic the exclusive and worldwide rights for the development and marketing of the new pharmaceutical drug.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.